[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO2506844T3 - - Google Patents

Info

Publication number
NO2506844T3
NO2506844T3 NO10781527A NO10781527A NO2506844T3 NO 2506844 T3 NO2506844 T3 NO 2506844T3 NO 10781527 A NO10781527 A NO 10781527A NO 10781527 A NO10781527 A NO 10781527A NO 2506844 T3 NO2506844 T3 NO 2506844T3
Authority
NO
Norway
Application number
NO10781527A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41573013&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO2506844(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of NO2506844T3 publication Critical patent/NO2506844T3/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D75/00—Packages comprising articles or materials partially or wholly enclosed in strips, sheets, blanks, tubes, or webs of flexible sheet material, e.g. in folded wrappers
    • B65D75/28—Articles or materials wholly enclosed in composite wrappers, i.e. wrappers formed by associating or interconnecting two or more sheets or blanks
    • B65D75/30—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding
    • B65D75/32—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents
    • B65D75/36—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents one sheet or blank being recessed and the other formed of relatively stiff flat sheet material, e.g. blister packages, the recess or recesses being preformed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Molecular Biology (AREA)
  • Composite Materials (AREA)
  • Mechanical Engineering (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO10781527A 2009-12-01 2010-11-29 NO2506844T3 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0921075.8A GB0921075D0 (en) 2009-12-01 2009-12-01 Novel combination of the therapeutic agents

Publications (1)

Publication Number Publication Date
NO2506844T3 true NO2506844T3 (no) 2018-05-19

Family

ID=41573013

Family Applications (2)

Application Number Title Priority Date Filing Date
NO10781527A NO2506844T3 (no) 2009-12-01 2010-11-29
NO2018018C NO2018018I2 (no) 2009-12-01 2018-06-04 Farmasøytisk kombinasjonsprodukt omfattende et farmasøytisk akseptabelt salt av umeklidinium (for eksempel umeklidiniumbromid), vilanterol eller et farmasøytisk akseptabelt salt derav (for eksempel vilanteroltrifenatat) og flutikasonfuroate

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO2018018C NO2018018I2 (no) 2009-12-01 2018-06-04 Farmasøytisk kombinasjonsprodukt omfattende et farmasøytisk akseptabelt salt av umeklidinium (for eksempel umeklidiniumbromid), vilanterol eller et farmasøytisk akseptabelt salt derav (for eksempel vilanteroltrifenatat) og flutikasonfuroate

Country Status (41)

Country Link
US (7) US20120309725A1 (no)
EP (3) EP4454645A1 (no)
JP (1) JP5816631B2 (no)
KR (2) KR101830728B1 (no)
CN (2) CN107412229A (no)
AU (6) AU2010326798B2 (no)
BR (1) BR112012012925A2 (no)
CA (1) CA2781487C (no)
CL (1) CL2012001432A1 (no)
CO (1) CO6541613A2 (no)
CR (1) CR20120265A (no)
CY (2) CY1120058T1 (no)
DK (2) DK2506844T3 (no)
DO (1) DOP2012000148A (no)
EA (1) EA023839B1 (no)
ES (2) ES2979060T3 (no)
FI (1) FI3335707T3 (no)
FR (1) FR18C1022I2 (no)
GB (1) GB0921075D0 (no)
HK (1) HK1249407A1 (no)
HR (2) HRP20240688T1 (no)
HU (3) HUE036216T2 (no)
IL (1) IL219893A (no)
LT (3) LT3335707T (no)
LU (1) LUC00077I2 (no)
MA (1) MA33853B1 (no)
ME (1) ME02965B (no)
MX (1) MX351290B (no)
MY (1) MY184864A (no)
NO (2) NO2506844T3 (no)
NZ (1) NZ600026A (no)
PE (2) PE20130042A1 (no)
PL (2) PL2506844T3 (no)
PT (2) PT3335707T (no)
RS (2) RS56848B1 (no)
SG (2) SG10201407864UA (no)
SI (2) SI3335707T1 (no)
TR (1) TR201802921T4 (no)
UA (1) UA106775C2 (no)
WO (1) WO2011067212A1 (no)
ZA (1) ZA201203890B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR050902A1 (es) 2004-04-27 2006-12-06 Glaxo Group Ltd Compuesto de quinuclidina, composicion farmaceutica que lo comprende y su usopara preparar dicha composicion
DK2400950T3 (da) 2009-02-26 2019-07-29 Glaxo Group Ltd Farmaceutiske formuleringer omfattende 4-{(1 r)-2-[(6-{2-[(2,6-dichlorbenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
ES2546422T5 (es) * 2010-08-31 2023-01-20 Glaxosmithkline Ip Dev Ltd Productos medicinales de inhalación de polvo seco que presentan propiedades de control de la humedad y procedimientos de administración de los mismos
SG195262A1 (en) * 2011-06-08 2013-12-30 Glaxo Group Ltd Combination comprising umeclidinium and a corticosteroid
BR112013031570A2 (pt) * 2011-06-08 2017-03-21 Glaxo Group Ltd inalador de pó seco.
BR112014025518B1 (pt) * 2012-04-13 2022-05-24 Glaxosmithkline Intellectual Property Development Limited Partículas agregadas de umeclidinium, vilanterol e fluticasona, composição em pó, inalador, processo para a preparação de partículas agregadas, e, uso de estearato de magnésio em partículas agregadas
GB201222679D0 (en) 2012-12-17 2013-01-30 Glaxo Group Ltd Pharmaceutical combination products
GB201305825D0 (en) 2013-03-28 2013-05-15 Vectura Ltd New use
EP3650019B8 (en) * 2014-05-28 2023-10-11 GlaxoSmithKline Intellectual Property Development Limited Fluticasone furoate in the treatment of copd
TR201407010A2 (tr) 2014-06-16 2015-12-21 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi Vilanterol formülasyonları.
EP2957552B1 (en) 2014-06-16 2020-01-22 Arven Ilac Sanayi Ve Ticaret A.S. Vilanterol formulations
WO2015193631A1 (en) 2014-06-18 2015-12-23 Cipla Limited Pharmaceutical composition comprising a beta-2-agonist and anticholinergic agent
WO2020100040A1 (en) * 2018-11-12 2020-05-22 3M Innovative Properties Company Umeclidinium and vilanterol formulation and inhaler
CN111840256A (zh) * 2019-04-29 2020-10-30 上海谷森医药有限公司 一种雾化吸入剂及其制备方法
CN112752572B (zh) 2019-05-23 2022-02-22 广州谷森制药有限公司 含有三苯乙酸维兰特罗和芜地溴铵的可吸入溶液组合物
CN115768404B (zh) * 2020-06-09 2024-11-08 广州谷森制药有限公司 含乌美溴铵和三苯乙酸维兰特罗的药物制剂

Family Cites Families (181)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB124009A (en) 1918-01-12 1919-03-12 Walter Edward Kimber Improvements in and connected with the Manufacture of Tools for Turning, Planing, Boring and similar purposes.
GB124010A (en) 1919-01-10 1919-03-20 Rene Emile Dior Improved Process for the Manufacture of Synthetic Resins.
GB1242211A (en) 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition
GB1381872A (en) 1971-06-22 1975-01-29 Fisons Ltd Pharmaceutical compositions for inhalation
FR2182892B1 (no) 1972-03-25 1976-11-05 Degussa
GB2064336B (en) 1979-12-06 1984-03-14 Glaxo Group Ltd Device for dispensing medicaments
DE3274065D1 (de) 1981-07-08 1986-12-11 Draco Ab Powder inhalator
US4778054A (en) 1982-10-08 1988-10-18 Glaxo Group Limited Pack for administering medicaments to patients
FR2550452B1 (fr) 1982-10-08 1992-05-22 Glaxo Group Ltd Dispositif pour administrer des medicaments a des patients
GB2169265B (en) 1982-10-08 1987-08-12 Glaxo Group Ltd Pack for medicament
CA1272917A (en) 1985-07-30 1990-08-21 Paul Kenneth Rand Devices for administering medicaments to patients
GB8530365D0 (en) 1985-12-10 1986-01-22 Univ Bath Manufacture of moulded products
IT1204826B (it) 1986-03-04 1989-03-10 Chiesi Farma Spa Composizioni farmaceutiche per inalazione
CA1329526C (en) 1987-08-20 1994-05-17 Hiroshi Ikura Powdery medicine applicator device
US4994276A (en) 1988-09-19 1991-02-19 Edward Mendell Co., Inc. Directly compressible sustained release excipient
GB8820353D0 (en) 1988-08-26 1988-09-28 Staniforth J N Controlled release tablet
US5135757A (en) 1988-09-19 1992-08-04 Edward Mendell Co., Inc. Compressible sustained release solid dosage forms
US5376386A (en) 1990-01-24 1994-12-27 British Technology Group Limited Aerosol carriers
SK280967B6 (sk) 1990-03-02 2000-10-09 Glaxo Group Limited Inhalačný prístroj
GB9004781D0 (en) 1990-03-02 1990-04-25 Glaxo Group Ltd Device
US6536427B2 (en) 1990-03-02 2003-03-25 Glaxo Group Limited Inhalation device
YU48707B (sh) 1990-03-02 1999-07-28 Glaxo Group Limited Aparat za inhaliranje - inhalator
FR2660634B1 (fr) 1990-04-06 1992-10-16 Airsec Ind Sa Conditionnement pour produits necessitant l'usage d'un agent deshydratant.
JPH0471560A (ja) 1990-07-10 1992-03-06 Mect Corp 包装体
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
DE4140689B4 (de) 1991-12-10 2007-11-22 Boehringer Ingelheim Kg Inhalationspulver und Verfahren zu ihrer Herstellung
DE69330672T2 (de) 1992-06-12 2002-06-27 Teijin Ltd., Osaka Pharmazeutische zubereitung zur anwendung in den atemwegen
KR100277622B1 (ko) 1992-06-12 2001-01-15 이타가키 히로시 흡입용 초미립자 분말 및 그의 제조방법
GB2269992A (en) 1992-08-14 1994-03-02 Rh Ne Poulenc Rorer Limited Powder inhalation formulations
KR100300691B1 (ko) 1992-09-09 2001-11-22 알 지 맥라이트 제약학적포장품
SE9203743D0 (sv) 1992-12-11 1992-12-11 Astra Ab Efficient use
KR0163472B1 (ko) 1992-12-18 1998-11-16 에릭 에스. 딕커 분말 약품용 흡입기
US5441060A (en) 1993-02-08 1995-08-15 Duke University Dry powder delivery system
ES2122261T3 (es) 1993-03-17 1998-12-16 Minnesota Mining & Mfg Formulacion de aerosol que contiene un adyuvante de dispersion derivado de un ester, una amida o un mercaptoester.
US5730785A (en) 1993-04-01 1998-03-24 Multisorb Technologies, Inc. Desiccant canister for desiccants and other particulate material
US5506203C1 (en) 1993-06-24 2001-02-06 Astra Ab Systemic administration of a therapeutic preparation
IS1796B (is) 1993-06-24 2001-12-31 Ab Astra Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband
DE4323636A1 (de) 1993-07-15 1995-01-19 Hoechst Ag Arzneistoffzubereitungen aus umhüllten, schwerstwasserlöslichen Arzneistoffen für Inhalationsarzneiformen und Verfahren zu ihrer Herstellung
GB9322014D0 (en) 1993-10-26 1993-12-15 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
US5503662A (en) 1994-03-29 1996-04-02 Multiform Desiccants, Inc. Canister with porous plastic ends
FI95441C (fi) 1994-05-31 1996-02-12 Leiras Oy Inhalointilaitteen lääkeainekammio
US6156231A (en) 1994-09-08 2000-12-05 Multisorb Technologies, Inc. Oxygen absorbing composition with cover layer
US5641425A (en) 1994-09-08 1997-06-24 Multiform Desiccants, Inc. Oxygen absorbing composition
AR002009A1 (es) 1994-12-22 1998-01-07 Astra Ab Composicion farmaceutica, procedimiento para la manufactura de un polvo de proliposoma como el utilizado en dicha composicion, procedimiento para lamanufactura de dicha composicion, uso de dicha composicion farmaceutica en la manufactura de un medicamento y dispositivo inhalador de polvo seco.
GB9501841D0 (en) 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
DE69630819T2 (de) 1995-04-19 2004-09-23 Csp Technologies, Inc. Geschlossener Behälter mit Trockenmittel
US6279736B1 (en) 1995-04-19 2001-08-28 Capitol Specialty Plastics, Inc. Barrier pack having an absorbing agent applied to the interior of the pack
GB9515182D0 (en) 1995-07-24 1995-09-20 Co Ordinated Drug Dev Improvements in and relating to powders for use in dry powder inhalers
GB9700226D0 (en) 1997-01-08 1997-02-26 Glaxo Group Ltd Inhalation device
US6103141A (en) 1997-01-23 2000-08-15 Multisorb Technologies, Inc. Desiccant deposit
US6126919A (en) 1997-02-07 2000-10-03 3M Innovative Properties Company Biocompatible compounds for pharmaceutical drug delivery systems
US6153322A (en) 1997-03-14 2000-11-28 Lee; T. Randall Methods for making fluorinated surface modifying agents, methods of using same and products made using same
US5985415A (en) 1997-11-17 1999-11-16 Reconnx, Inc. Finger joint architecture for wood products, and method and apparatus for formation thereof
US6086376A (en) 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant
DE69925386T2 (de) 1998-02-05 2006-01-19 E.I. Du Pont De Nemours And Co., Wilmington Verfahren zur Erhöhung des Feuchtigkeitsgehalts in einem getrockneten Material
ATE228823T1 (de) 1998-04-18 2002-12-15 Glaxo Group Ltd Pharmazeutische aerosolformulierung
US7521068B2 (en) 1998-11-12 2009-04-21 Elan Pharma International Ltd. Dry powder aerosols of nanoparticulate drugs
US20070212422A1 (en) 1999-11-10 2007-09-13 Manfred Keller Dry powder for inhalation
NZ511527A (en) 1998-11-13 2002-10-25 Jago Res A Dry powder for inhalation
GB9827145D0 (en) 1998-12-09 1999-02-03 Co Ordinated Drug Dev Improvements in or relating to powders
US6352152B1 (en) 1998-12-18 2002-03-05 Smithkline Beecham Corporation Method and package for storing a pressurized container containing a drug
US6390291B1 (en) 1998-12-18 2002-05-21 Smithkline Beecham Corporation Method and package for storing a pressurized container containing a drug
US6315112B1 (en) 1998-12-18 2001-11-13 Smithkline Beecham Corporation Method and package for storing a pressurized container containing a drug
US6119853A (en) 1998-12-18 2000-09-19 Glaxo Wellcome Inc. Method and package for storing a pressurized container containing a drug
DE69936268T2 (de) 1999-03-05 2008-02-14 Chiesi Farmaceutici S.P.A. Verbesserte pulverförmige pharmazeutische Zusammensetzungen zur Verwendung in Trockenpulverinhalatoren
IT1309592B1 (it) 1999-03-05 2002-01-24 Chiesi Farma Spa Particelle veicolo modificate da utilizzarsi nella preparazione diformulazioni farmaceutiche sotto forma di polimeri per inalazione e
USD440874S1 (en) 1999-07-29 2001-04-24 The Gillette Company Container
IL149027A0 (en) 1999-10-11 2002-11-10 Ml Lab Plc Medicament delivery device with moisture resistant coating
DE19957802A1 (de) 1999-12-01 2001-06-07 Trw Repa Gmbh Gurtaufrollersystem
GB0008660D0 (en) 2000-04-07 2000-05-31 Arakis Ltd The treatment of respiratory diseases
US20030026766A1 (en) 2000-04-13 2003-02-06 Mark Sanders Medicaments for treating respiratory disorders comprising formoterol and fluticasone
PE20011227A1 (es) 2000-04-17 2002-01-07 Chiesi Farma Spa Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
WO2001087731A2 (en) 2000-05-15 2001-11-22 Glaxo Group Limited Aerosol mdi overcap containing desiccant
GB0015043D0 (en) 2000-06-21 2000-08-09 Glaxo Group Ltd Medicament dispenser
AU2001270074A1 (en) 2000-06-22 2002-01-02 Glaxo Group Limited Method and package for storing a pressurized container containing a drug
GB0019172D0 (en) 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
ES2317922T3 (es) 2000-08-05 2009-05-01 Glaxo Group Limited Derivados de beta-carbotioato 17, alfa-acrilcarboniloxiloxi androstano como agentes antiinflamatorios.
DE10056855A1 (de) 2000-11-16 2002-05-29 Lohmann Therapie Syst Lts Verbundlaminat mit Sauerstoff und Feuchtigkeit absorbierender Schicht und Verfahren zu seiner Herstellung
ES2708961T3 (es) 2000-11-30 2019-04-12 Vectura Ltd Composiciones farmacéuticas para inhalación
ATE446085T1 (de) 2000-11-30 2009-11-15 Vectura Ltd Partikel zur verwendung in einer pharmazeutischen zusammensetzung
EP1241110A1 (en) 2001-03-16 2002-09-18 Pfizer Products Inc. Dispensing unit for oxygen-sensitive drugs
EP1243524A3 (en) 2001-03-16 2004-04-07 Pfizer Products Inc. Pharmaceutical kit for oxygen-sensitive drugs
UA77656C2 (en) 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
DE10126924A1 (de) 2001-06-01 2002-12-05 Boehringer Ingelheim Pharma Inhalationskapseln
NZ531651A (en) * 2001-09-14 2006-02-24 Glaxo Group Ltd Phenethanolamine derivatives for treatment of respiratory diseases
AU2002351271A1 (en) 2001-12-21 2003-07-24 Nektar Therapeutics Capsule package with moisture barrier
GB0201677D0 (en) 2002-01-25 2002-03-13 Glaxo Group Ltd Medicament dispenser
GB0208608D0 (en) * 2002-04-13 2002-05-22 Glaxo Group Ltd Composition
US20030203141A1 (en) 2002-04-25 2003-10-30 Blum John B. Blister package
US20040131805A1 (en) 2002-06-20 2004-07-08 Merical Rick L. Films having a desiccant material incorporated therein and methods of use and manufacture
US20060269708A1 (en) 2002-06-20 2006-11-30 Rick Merical Films having a desiccant material incorporated therein and methods of use and manufacture
US20030235664A1 (en) 2002-06-20 2003-12-25 Rick Merical Films having a desiccant material incorporated therein and methods of use and manufacture
US8003179B2 (en) 2002-06-20 2011-08-23 Alcan Packaging Flexible France Films having a desiccant material incorporated therein and methods of use and manufacture
US20060236868A1 (en) 2003-05-19 2006-10-26 Bester Pansegrouw Dessicant container
GB0312148D0 (en) 2003-05-28 2003-07-02 Aventis Pharma Ltd Stabilized pharmaceutical products
SE527191C2 (sv) 2003-06-19 2006-01-17 Microdrug Ag Inhalatoranordning samt kombinerade doser av tiotropium och fluticason
GB0315889D0 (en) 2003-07-08 2003-08-13 Aventis Pharma Ltd Stable pharmaceutical products
KR100486016B1 (ko) 2003-07-09 2005-04-29 주식회사종근당 타크로리무스의 속용성 고체분산체 및 이의 제조방법
GB0316341D0 (en) 2003-07-11 2003-08-13 Glaxo Group Ltd Pharmaceutical formulations
WO2005004845A1 (en) 2003-07-11 2005-01-20 Glaxo Group Limited Pharmaceutical formulations comprising magnesium stearate
US20050072958A1 (en) 2003-10-02 2005-04-07 Thomas Powers Oxygen scavenger for low moisture environment and methods of using the same
ES2358673T3 (es) 2003-10-14 2011-05-12 Glaxo Group Limited Antagonistas de receptores de acetilcolina muscarínicos.
WO2005044186A2 (en) 2003-10-28 2005-05-19 Glaxo Group Limited Inhalable pharmaceutical formulations employing desiccating agents and methods of administering the same
GB0326632D0 (en) * 2003-11-14 2003-12-17 Jagotec Ag Dry powder formulations
SE0303569L (sv) 2003-12-03 2005-06-04 Microdrug Ag DPI för avlämning av fuktkänsliga medikament
AU2004294890B2 (en) 2003-12-03 2010-08-26 Boehringer Ingelheim International Gmbh Pre-metered dry powder inhaler for moisture-sensitive medicaments
SE0303570L (sv) 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
SE0303269L (sv) 2003-12-03 2005-06-04 Microdrug Ag Medicinsk produkt
AU2004294889B2 (en) 2003-12-03 2010-08-26 Boehringer Ingelheim International Gmbh Medical product containing tiotropium
SE0303270L (sv) 2003-12-03 2005-06-04 Microdrug Ag Metod för administration av tiotropium
GB2410192B (en) 2004-01-23 2005-12-07 Eg Technology Ltd An inhaler
AR050902A1 (es) 2004-04-27 2006-12-06 Glaxo Group Ltd Compuesto de quinuclidina, composicion farmaceutica que lo comprende y su usopara preparar dicha composicion
GB0409703D0 (en) 2004-04-30 2004-06-02 Vectura Ltd Pharmaceutical compositions
ES2257152B1 (es) 2004-05-31 2007-07-01 Laboratorios Almirall S.A. Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos.
RS50786B (sr) 2004-05-31 2010-08-31 Laboratorios Almirall S.A. Kombinacije koje sadrže antimuskarinska sredstva i beta-adrenergične agoniste
SE530006C2 (sv) 2004-06-18 2008-02-05 Mederio Ag Inhalator som använder balja
SE0401654D0 (sv) 2004-06-24 2004-06-24 Astrazeneca Ab A support structure for a medicament
GB0416397D0 (en) 2004-07-22 2004-08-25 Glaxo Group Ltd Pharmaceutical formulations
EP1778626A1 (en) 2004-08-16 2007-05-02 Theravance, Inc. Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
UA95063C2 (ru) 2004-10-21 2011-07-11 Бёрингер Ингельхайм Интернациональ Гмбх Блистерная упаковка для применения в ингаляторах
US7501011B2 (en) 2004-11-09 2009-03-10 Multisorb Technologies, Inc. Humidity control device
SE0402976L (sv) 2004-12-03 2006-06-04 Mederio Ag Medicinsk produkt
PE20060826A1 (es) 2004-12-06 2006-10-08 Smithkline Beecham Corp Derivado oleofinico de 8-azoniabiciclo[3.2.1]octano y combinacion farmaceutica que lo comprende
PE20061162A1 (es) 2004-12-06 2006-10-14 Smithkline Beecham Corp Compuestos derivados olefinicos de 8-azoniabiciclo[3.2.1]octanos
US7938580B2 (en) 2004-12-08 2011-05-10 Perfecseal, Inc. Sterilizable package with a high barrier to oxygen
AU2005322023A1 (en) 2004-12-27 2006-07-06 King Pharmaceuticals Oxygen-impervious packaging and methods for storing thyroid hormone
US20060144733A1 (en) 2004-12-30 2006-07-06 3M Innovative Properties Company Container assembly and method for humidity control
JP2008529773A (ja) 2005-02-10 2008-08-07 グラクソ グループ リミテッド 医薬製剤に使用するためのラクトース粒子の結晶化方法
ES2613391T3 (es) 2005-02-10 2017-05-24 Glaxo Group Limited Procedimientos de fabricación de lactosa que utilizan técnicas de preclasificación y formulaciones farmacéuticas formadas a partir de la misma
DE202005002409U1 (de) 2005-02-15 2005-07-07 Microdrug Ag Inhalierbares Tiotropium und Behälter dafür
DE202005004659U1 (de) 2005-03-22 2005-07-07 Microdrug Ag Vordosierter Trockenpulverinhalator für feuchtigkeitsempfindliche Medikamente
GB0507165D0 (en) 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
JP4659523B2 (ja) 2005-04-26 2011-03-30 共同印刷株式会社 ブリスター用フィルム及びブリスター用包装容器
WO2006124556A2 (en) 2005-05-13 2006-11-23 Glaxo Group Limited Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same
DE102005022862A1 (de) 2005-05-18 2006-12-14 Airsec S.A.S Kapseln für Inhalatoren
GB0523653D0 (en) * 2005-11-21 2005-12-28 Novartis Ag Organic compounds
US20060278965A1 (en) 2005-06-10 2006-12-14 Foust Donald F Hermetically sealed package and methods of making the same
GB0515584D0 (en) 2005-07-28 2005-09-07 Glaxo Group Ltd Medicament dispenser
WO2007037748A1 (en) 2005-09-28 2007-04-05 Mederio Ag Inhaler device for moisture sensitive drugs and method of operating an inhaler device.
GB0520794D0 (en) 2005-10-12 2005-11-23 Innovata Biomed Ltd Inhaler
PL1780005T3 (pl) 2005-10-18 2009-07-31 Alcan Tech & Management Ltd Laminat formowalny na zimno dla korpusu blistra
EP1787800A1 (de) 2005-11-17 2007-05-23 Alcan Technology & Management Ltd. Kaltverformbares Laminat für Blisterbodenteile
AR058289A1 (es) 2005-12-12 2008-01-30 Glaxo Group Ltd Colector para ser usado en dispensador de medicamento
EP1990052B1 (en) 2006-02-27 2012-05-16 Takeda Pharmaceutical Company Limited Pharmaceutical package comprising 2-ethoxy-1-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl}-1h-benzimidazole-7-carboxylic acid (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl or 2-cyclopropyl-1-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl}-1h-benzimidazole-7-carboxylic acid (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl and a desiccant.
KR100764640B1 (ko) 2006-03-08 2007-10-10 세원셀론텍(주) 지방조직 수복용 키트
WO2007109606A2 (en) 2006-03-17 2007-09-27 Csp Technologies, Inc. Moisture-tight primary packaging for a dry powder inhaler
AU2007226899A1 (en) 2006-03-22 2007-09-27 3M Innovative Properties Company Novel formulations
JP2009532339A (ja) 2006-03-22 2009-09-10 スリーエム イノベイティブ プロパティズ カンパニー 新規製剤
WO2007109824A1 (en) 2006-03-24 2007-10-04 Ian Simon Tracton Stable packaged dosage form and process therefor
JP2010526763A (ja) 2006-05-24 2010-08-05 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 呼吸器系疾患を治療するための新規な長時間作用型の薬剤組成物
GB0615108D0 (en) 2006-07-28 2006-09-06 Glaxo Group Ltd Novel formulations
JP2009545343A (ja) 2006-08-03 2009-12-24 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング 医薬製剤を含むパック
EP2049086A2 (en) 2006-08-09 2009-04-22 Glaxo Group Limited Process for manufacturing lactose
EP2049693A2 (en) 2006-08-09 2009-04-22 Glaxo Group Limited Process for manufacturing lactose
FI20065636A0 (fi) 2006-10-04 2006-10-04 Lab Pharma Ltd Dessikanttijärjestelmä irtohaloitavien jauheiden kosteuden säätämiseksi
US20100099651A1 (en) 2006-10-26 2010-04-22 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
US20080178559A1 (en) 2007-01-26 2008-07-31 Multisorb Technologies, Inc. Sorbent Packaging
KR101358054B1 (ko) 2007-03-29 2014-02-13 멀티서브 테크놀로지스 인코포레이티드 패키징 용도를 위한 흡착성 복합물 장벽을 선택하는 방법
US7549272B2 (en) 2007-04-16 2009-06-23 Multisorb Technologies, Inc. Sorbent canister with beveled edges
EP2155582B2 (en) 2007-05-07 2018-10-03 Clariant Production (France) S.A.S. Container with moisture control capacity
PE20090907A1 (es) 2007-07-21 2009-08-05 Boehringer Ingelheim Int Nuevos medicamentos pulverulentos que contienen tiotropio y salmeterol, asi como lactosa como excipiente
UY31233A1 (es) 2007-07-21 2009-03-02 Unidades de envasado con un agente desecante
WO2009029029A1 (en) 2007-08-24 2009-03-05 Astrazeneca Ab Inhaler for powdered substances with desiccant compartment
WO2009036243A1 (en) 2007-09-12 2009-03-19 Glaxo Group Limited Novel combination of therapeutic agents
EP2080523A1 (en) 2008-01-15 2009-07-22 CHIESI FARMACEUTICI S.p.A. Compositions comprising an antimuscarinic and a long-acting beta-agonist
JP2011512209A (ja) 2008-02-20 2011-04-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 粉末吸入器
JP4983657B2 (ja) 2008-03-11 2012-07-25 富士通株式会社 電子メール管理プログラム、該プログラムを記録した記録媒体、通信端末、および電子メール管理方法
EP2127628A1 (en) 2008-05-27 2009-12-02 Ranbaxy Laboratories Limited Unit dose pack
US9095324B2 (en) 2008-06-20 2015-08-04 Boston Scientific Scimed, Inc. Package assembly
JP2012504591A (ja) 2008-10-02 2012-02-23 レスピバート・リミテツド ｐ３８ＭＡＰキナーゼ阻害剤
UY32297A (es) 2008-12-22 2010-05-31 Almirall Sa Sal mesilato de 5-(2-{[6-(2,2-difluoro-2-fenilitoxi) hexil]amino}-1-hidroxietil)-8-hidroxiquinolin-2( 1h)-ona como agonista del receptor b(beta)2 acrenérgico
WO2010097114A1 (en) * 2009-02-26 2010-09-02 Glaxo Group Limited Novel combination of therapeutic agents
DK2400950T3 (da) * 2009-02-26 2019-07-29 Glaxo Group Ltd Farmaceutiske formuleringer omfattende 4-{(1 r)-2-[(6-{2-[(2,6-dichlorbenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol
EP3260152B1 (en) 2009-05-18 2019-12-18 Adamis Pharmaceuticals Corporation Dry powder inhalers
DK2277799T3 (da) 2009-07-23 2012-05-21 Airsec Sas Hydreret fugtighedsbekæmpelsesstof og fremgangsmåde til fremstilling deraf
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
ES2546422T5 (es) 2010-08-31 2023-01-20 Glaxosmithkline Ip Dev Ltd Productos medicinales de inhalación de polvo seco que presentan propiedades de control de la humedad y procedimientos de administración de los mismos
BR112013031570A2 (pt) 2011-06-08 2017-03-21 Glaxo Group Ltd inalador de pó seco.
SG195262A1 (en) 2011-06-08 2013-12-30 Glaxo Group Ltd Combination comprising umeclidinium and a corticosteroid
GB201222679D0 (en) 2012-12-17 2013-01-30 Glaxo Group Ltd Pharmaceutical combination products

Also Published As

Publication number Publication date
EP4454645A1 (en) 2024-10-30
CN107412229A (zh) 2017-12-01
JP5816631B2 (ja) 2015-11-18
NO2018018I1 (no) 2018-06-04
HUE066359T2 (hu) 2024-07-28
US9750726B2 (en) 2017-09-05
FI3335707T3 (fi) 2024-07-05
FR18C1022I2 (fr) 2020-03-20
IL219893A0 (en) 2012-07-31
ZA201203890B (en) 2013-11-27
KR20120092163A (ko) 2012-08-20
CO6541613A2 (es) 2012-10-16
KR101742140B1 (ko) 2017-05-31
PL3335707T3 (pl) 2024-07-29
CA2781487C (en) 2018-10-16
DOP2012000148A (es) 2012-07-31
CL2012001432A1 (es) 2012-10-05
JP2013512270A (ja) 2013-04-11
UA106775C2 (uk) 2014-10-10
IL219893A (en) 2017-01-31
KR20170061719A (ko) 2017-06-05
EP3335707B1 (en) 2024-04-17
DK3335707T3 (da) 2024-05-21
CY2018017I1 (el) 2018-09-05
AU2010326798A1 (en) 2012-06-21
GB0921075D0 (en) 2010-01-13
PE20170915A1 (es) 2017-07-12
ES2979060T3 (es) 2024-09-24
NO2018018I2 (no) 2018-06-04
US20180008582A1 (en) 2018-01-11
HUE036216T2 (hu) 2018-06-28
SG181087A1 (en) 2012-07-30
US20240041846A1 (en) 2024-02-08
US11090294B2 (en) 2021-08-17
EP2506844A1 (en) 2012-10-10
LT2506844T (lt) 2018-03-12
AU2016262698A1 (en) 2016-12-15
RS56848B1 (sr) 2018-04-30
AU2016262698B2 (en) 2018-10-25
MX2012006310A (es) 2012-06-19
PT2506844T (pt) 2018-02-28
MX351290B (es) 2017-10-09
AU2018282427A1 (en) 2019-01-17
US20220235087A1 (en) 2022-07-28
AU2010326798B2 (en) 2014-08-07
AU2014204459A1 (en) 2014-07-31
EA023839B1 (ru) 2016-07-29
CR20120265A (es) 2012-08-14
LUC00077I2 (en) 2018-08-14
US20160095840A1 (en) 2016-04-07
LT3335707T (lt) 2024-06-10
LTC2506844I2 (lt) 2022-10-10
EP3335707A1 (en) 2018-06-20
AU2021204302A1 (en) 2021-07-22
HK1249407A1 (zh) 2018-11-02
FR18C1022I1 (no) 2018-07-13
DK2506844T3 (en) 2018-02-05
EA201290266A1 (ru) 2013-02-28
CA2781487A1 (en) 2011-06-09
SI3335707T1 (sl) 2024-07-31
HUS1800027I1 (hu) 2018-08-28
US20200171009A1 (en) 2020-06-04
TR201802921T4 (tr) 2018-03-21
PL2506844T3 (pl) 2018-06-29
US20120309725A1 (en) 2012-12-06
AU2014204459B2 (en) 2016-08-25
ME02965B (me) 2018-07-20
PE20130042A1 (es) 2013-02-09
EP2506844B1 (en) 2017-12-20
CY2018017I2 (el) 2018-09-05
RS65494B1 (sr) 2024-05-31
NZ600026A (en) 2014-06-27
HRP20240688T1 (hr) 2024-08-30
CY1120058T1 (el) 2018-09-05
PT3335707T (pt) 2024-05-29
AU2018282427C1 (en) 2022-06-30
HRP20180312T1 (hr) 2018-03-23
SI2506844T1 (en) 2018-04-30
MA33853B1 (fr) 2012-12-03
BR112012012925A2 (pt) 2016-08-16
LTPA2018011I1 (lt) 2018-06-25
AU2023219901A1 (en) 2023-09-14
MY184864A (en) 2021-04-28
ES2659330T3 (es) 2018-03-14
AU2018282427B2 (en) 2021-04-01
KR101830728B1 (ko) 2018-04-04
US20220047565A1 (en) 2022-02-17
WO2011067212A1 (en) 2011-06-09
CN102724974A (zh) 2012-10-10
SG10201407864UA (en) 2014-12-30

Similar Documents

Publication Publication Date Title
FR18C1022I1 (no)
BE2015C040I2 (no)
BRPI0925311A2 (no)
BR112012008195A2 (no)
BR112012003062A2 (no)
BRPI0924307A2 (no)
BR112012012396A2 (no)
BR112012008267A2 (no)
BR112012000607A2 (no)
BR122021004633A2 (no)
BR112012003080A2 (no)
BR122017024704A2 (no)
BR112012000665A2 (no)
BR112012012487A2 (no)
BR112012003853A2 (no)
BR112012012080A2 (no)
BR112012009797A2 (no)
BR112012009446A2 (no)
BR112012009703A2 (no)
BR112012010357A2 (no)
BR112012007656A2 (no)
BR112012001263A2 (no)
BR112012002627A2 (no)
BR122019005883A2 (no)
BRPI0924534A2 (no)